Morgan Stanley (MS-PQ) wird mit einem nachlaufenden KGV von gehandelt 16.4. Die nachlaufende Gewinnrendite beträgt 6.10%. PEG 0.58 (Peter Lynch unterbewertet ≤1,0). Die Graham-Zahl beträgt $131.59.
Durch diese Seite bewiesene Kriterien:
SharesGrow Gesamtbewertung: 62/100 mit 3/7 Kriterien bestanden.
| Year | P/E (TTM) | PEG-Verhältnis | P/B-Verhältnis | P/S-Verhältnis | Dividendenrendite |
|---|---|---|---|---|---|
| 2016 | 13.1 | 0.00 | 1.03 | 2.17 | 2.24% |
| 2017 | 17.0 | 2.99 | 1.35 | 2.51 | 2.00% |
| 2018 | 7.7 | 0.15 | 0.84 | 1.42 | 3.51% |
| 2019 | 9.1 | 1.00 | 1.01 | 1.61 | 3.18% |
| 2020 | 10.0 | 0.41 | 1.08 | 2.21 | 2.49% |
| 2021 | 11.7 | 0.47 | 1.66 | 3.03 | 2.38% |
| 2022 | 13.0 | -0.55 | 1.44 | 2.30 | 3.76% |
| 2023 | 16.7 | -1.05 | 1.53 | 1.72 | 3.80% |
| 2024 | 14.9 | 0.28 | 1.91 | 1.94 | 3.07% |
| 2025 | 16.5 | 0.58 | 2.50 | 2.43 | 2.36% |
| Year | EPS (verwässert) | Umsatz | Nettogewinn | Nettomarge |
|---|---|---|---|---|
| 2016 | $2.92 | $32.71B | $5.98B | 18.3% |
| 2017 | $3.07 | $35.85B | $6.11B | 17% |
| 2018 | $5.03 | $37.71B | $8.75B | 23.2% |
| 2019 | $5.19 | $38.93B | $9.04B | 23.2% |
| 2020 | $6.47 | $45.27B | $11B | 24.3% |
| 2021 | $8.03 | $57.78B | $15.03B | 26% |
| 2022 | $6.15 | $62.48B | $11.03B | 17.7% |
| 2023 | $5.18 | $53.61B | $9.09B | 16.9% |
| 2024 | $7.95 | $57.62B | $13.39B | 23.2% |
| 2025 | $10.20 | $114.98B | $16.86B | 14.7% |
| Year | EPS (Durchschn.) | EPS-Spanne | Umsatz (Durchschn.) | Umsatzspanne | Analysten |
|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 – $0.00 | $76.58B | $74.73B – $78.84B | 0 |
| 2027 | $0.00 | $0.00 – $0.00 | $80.54B | $77.07B – $83.8B | 0 |
